Found 208 matching trials
JSKN003 Combined Treatment of HER2-positive Gastric Cancer
PHASE2This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Location
Multiple Locations
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
PHASE2To seek the efficacy signals of trastuzumab in combination with chemotherap...
Location
Beijing Cancer Hospital
Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer
PHASE3The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Location
Sun Yat-sen University Cancer Center
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
PHASE3Breast cancer is the most common malignant tumor in women. Recurrent or met...
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer
PHASE2This single arm study will assess the efficacy and safety of Avastin in com...
Location
Multiple Locations
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
PHASE2RATIONALE: Drugs used in chemotherapy, such as capecitabine and vinorelbine...
Location
Mayo Clinic Scottsdale
Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX
PHASE2This is an open-label, multicentre, prospective phase II trial designed to ...
Location
Asan Medical Center
Neoadjuvant Treatment of Breast Cancer
N/AObservational investigation of participants who are given neoadjuvant treat...
Location
National Institute of Oncolgy
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
PHASE2Purpose of the Study:
This clinical study investigates whether a shorter o...
Location
Amsterdam University Medical Center
APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)
PHASE2This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Location
Arizona Clinical Research Center